335 related articles for article (PubMed ID: 12165517)
1. Repression of AP-1 function: a mechanism for the regulation of Blimp-1 expression and B lymphocyte differentiation by the B cell lymphoma-6 protooncogene.
Vasanwala FH; Kusam S; Toney LM; Dent AL
J Immunol; 2002 Aug; 169(4):1922-9. PubMed ID: 12165517
[TBL] [Abstract][Full Text] [Related]
2. B-ATF functions as a negative regulator of AP-1 mediated transcription and blocks cellular transformation by Ras and Fos.
Echlin DR; Tae HJ; Mitin N; Taparowsky EJ
Oncogene; 2000 Mar; 19(14):1752-63. PubMed ID: 10777209
[TBL] [Abstract][Full Text] [Related]
3. A role for c-fos/activator protein 1 in B lymphocyte terminal differentiation.
Ohkubo Y; Arima M; Arguni E; Okada S; Yamashita K; Asari S; Obata S; Sakamoto A; Hatano M; O-Wang J; Ebara M; Saisho H; Tokuhisa T
J Immunol; 2005 Jun; 174(12):7703-10. PubMed ID: 15944271
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional repression by the proto-oncogene BCL-6.
Seyfert VL; Allman D; He Y; Staudt LM
Oncogene; 1996 Jun; 12(11):2331-42. PubMed ID: 8649773
[TBL] [Abstract][Full Text] [Related]
5. Assessment of the role of activator protein-1 on transcription of the mouse steroidogenic acute regulatory protein gene.
Manna PR; Eubank DW; Stocco DM
Mol Endocrinol; 2004 Mar; 18(3):558-73. PubMed ID: 14673133
[TBL] [Abstract][Full Text] [Related]
6. BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control.
Shaffer AL; Yu X; He Y; Boldrick J; Chan EP; Staudt LM
Immunity; 2000 Aug; 13(2):199-212. PubMed ID: 10981963
[TBL] [Abstract][Full Text] [Related]
7. The t(8;21) fusion protein, AML1/ETO, transforms NIH3T3 cells and activates AP-1.
Frank RC; Sun X; Berguido FJ; Jakubowiak A; Nimer SD
Oncogene; 1999 Mar; 18(9):1701-10. PubMed ID: 10208431
[TBL] [Abstract][Full Text] [Related]
8. Functional analysis of fish BCL-6 and Blimp-1 in vitro: transcriptional repressors for B-cell terminal differentiation in fugu (Takifugu rubripes).
Ohtani M; Miyadai T
Mol Immunol; 2011 Mar; 48(6-7):818-25. PubMed ID: 21216469
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional repression by blimp-1 (PRDI-BF1) involves recruitment of histone deacetylase.
Yu J; Angelin-Duclos C; Greenwood J; Liao J; Calame K
Mol Cell Biol; 2000 Apr; 20(7):2592-603. PubMed ID: 10713181
[TBL] [Abstract][Full Text] [Related]
10. The BCL-6 POZ domain and other POZ domains interact with the co-repressors N-CoR and SMRT.
Huynh KD; Bardwell VJ
Oncogene; 1998 Nov; 17(19):2473-84. PubMed ID: 9824158
[TBL] [Abstract][Full Text] [Related]
11. Effectors and memories: Bcl-6 and Blimp-1 in T and B lymphocyte differentiation.
Crotty S; Johnston RJ; Schoenberger SP
Nat Immunol; 2010 Feb; 11(2):114-20. PubMed ID: 20084069
[TBL] [Abstract][Full Text] [Related]
12. Induction of the RelB NF-kappaB subunit by the cytomegalovirus IE1 protein is mediated via Jun kinase and c-Jun/Fra-2 AP-1 complexes.
Wang X; Sonenshein GE
J Virol; 2005 Jan; 79(1):95-105. PubMed ID: 15596805
[TBL] [Abstract][Full Text] [Related]
13. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
[TBL] [Abstract][Full Text] [Related]
14. AP-1 transrepressing retinoic acid does not deplete coactivators or AP-1 monomers but may target specific Jun or Fos containing dimers.
Suzukawa K; Colburn NH
Oncogene; 2002 Mar; 21(14):2181-90. PubMed ID: 11948401
[TBL] [Abstract][Full Text] [Related]
15. [Bcl-6: a protooncogene co-involved in B-lymphocyte differentiation and in the pathogenesis of diffuse, large-cell non-Hodgkin's lymphomas of the B phenotype].
Pescarmona E
Pathologica; 1998 Feb; 90(1):81-2. PubMed ID: 9628984
[No Abstract] [Full Text] [Related]
16. Blimp-1-dependent repression of Pax-5 is required for differentiation of B cells to immunoglobulin M-secreting plasma cells.
Lin KI; Angelin-Duclos C; Kuo TC; Calame K
Mol Cell Biol; 2002 Jul; 22(13):4771-80. PubMed ID: 12052884
[TBL] [Abstract][Full Text] [Related]
17. Suppression of signal transducer and activator of transcription 3-dependent B lymphocyte terminal differentiation by BCL-6.
Reljic R; Wagner SD; Peakman LJ; Fearon DT
J Exp Med; 2000 Dec; 192(12):1841-8. PubMed ID: 11120780
[TBL] [Abstract][Full Text] [Related]
18. NF-kappaB and AP-1 connection: mechanism of NF-kappaB-dependent regulation of AP-1 activity.
Fujioka S; Niu J; Schmidt C; Sclabas GM; Peng B; Uwagawa T; Li Z; Evans DB; Abbruzzese JL; Chiao PJ
Mol Cell Biol; 2004 Sep; 24(17):7806-19. PubMed ID: 15314185
[TBL] [Abstract][Full Text] [Related]
19. Menin uncouples Elk-1, JunD and c-Jun phosphorylation from MAP kinase activation.
Gallo A; Cuozzo C; Esposito I; Maggiolini M; Bonofiglio D; Vivacqua A; Garramone M; Weiss C; Bohmann D; Musti AM
Oncogene; 2002 Sep; 21(42):6434-45. PubMed ID: 12226747
[TBL] [Abstract][Full Text] [Related]
20. The inhibitory activity of a transdominant c-jun mutant fused to the ligand binding domain of the estrogen receptor.
Kim S; Brown PH; Birrer MJ
Oncogene; 1996 Mar; 12(5):1043-53. PubMed ID: 8649795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]